<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">van Calster, Geert</style></author><author><style face="normal" font="default" size="100%">D'Silva, Joel</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Taking temperature–a review of European Union regulation in nanomedicine.</style></title><secondary-title><style face="normal" font="default" size="100%">European Journal of Health Law</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2009</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2009</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1285099</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">3</style></volume><pages><style face="normal" font="default" size="100%">249-69</style></pages><isbn><style face="normal" font="default" size="100%">0929-0273</style></isbn><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">After introducing some of the current and future uses nanotechnology will have in healthcare applications, the authors discuss the current regulatory framework in the European Union that govern medical products, devices, biologics and therapies. The paper concludes by analyzing two nanotechnology applications, and the regulatory challenges they raise, and discusses the adequacy of the current system to deal with these challenges. Link to abstract in PubMed.</style></abstract><work-type><style face="normal" font="default" size="100%">Journal Article</style></work-type></record></records></xml>